Why a psychiatrist directs our medical aesthetics practice

Most medical spas in Canada list a physician medical director somewhere in the fine print. Most of them are dermatologists, plastic surgeons, family physicians, or emergency physicians whose involvement amounts to a periodic chart review and a signature on regulatory paperwork. We chose to do this differently.

Dr. John David Henneberry-Fudge is a Royal College–certified psychiatrist with hospital privileges at Hamilton Health Sciences and St Joseph’s Healthcare Hamilton. He is the Medical Director of Bar Beauty Medical. He does not personally administer Botox, dermal filler, threadlifts, or device treatments at our clinic — those are performed exclusively by our licensed registered nurse injectors and aesthetic physicians. His role is upstream of the syringe and downstream of every consultation: clinical governance, protocol design, adverse-event escalation, and the most under-discussed problem in our industry — patient psychology.

The problem this addresses: BDD in cosmetic patients

Body Dysmorphic Disorder (BDD) is a recognized DSM-5 psychiatric condition characterized by preoccupation with one or more perceived defects in physical appearance that are not observable or appear slight to others. In the general population, BDD prevalence is estimated at 1.7–2.4%. In cosmetic dermatology and cosmetic surgery patient populations, multiple peer-reviewed studies place prevalence between 9% and 21% — roughly an order of magnitude higher. (See: Veale et al., Br J Dermatol; Crerand et al., Plast Reconstr Surg; Conrado et al., J Am Acad Dermatol.)

The clinical consensus is unambiguous: patients with active BDD do not get better from cosmetic intervention. They tend to feel worse, escalate their requests, develop preoccupations with new areas of the body, and a meaningful subset become litigious or threatening toward their providers. Treating active BDD with filler, neurotoxin, or surgical intervention is, in the framing of the field’s own literature, contraindicated — not because the technique fails, but because the underlying disorder is what creates the dissatisfaction, not the appearance.

Despite this, BDD screening is rarely performed in commercial medical aesthetics practice in Canada. There is no provincial regulation requiring it. There is no requirement that the injector even know what BDD is. We think that needs to change, and we have built our practice accordingly.

What this means in practice at Bar Beauty Medical

Pre-injectable screening using validated instruments

For first-time injectable patients — particularly those presenting for lip filler, repeat full-face volumization, or rhinoplasty-adjacent procedures — we administer a brief validated screen as part of intake. The most commonly used in our setting is the BDDQ (Body Dysmorphic Disorder Questionnaire), a short self-report instrument. Positive screens prompt a longer clinical conversation, and where appropriate, we either defer treatment or decline to treat. Our injectors are trained to recognize the clinical patterns that warrant escalation regardless of questionnaire score — repeat photo comparison anxiety, requests for treatments that contradict objective findings, history of multiple recent procedures at multiple clinics, and others.

Right of refusal, exercised regularly

This is the part that distinguishes a medical practice from a beauty service. We turn patients away. Not often, but often enough that our injectors have a clear protocol for it. Most often it is a lip filler consult where a patient is asking for volume that cannot be safely accommodated by their lip anatomy. Sometimes it is a full-face request where the patient’s described concerns are not visible to a trained observer or to clinical photography. Sometimes it is a patient who has had filler injected and dissolved repeatedly across multiple clinics over the last twelve months. These are not the patients you make money on. These are the patients you protect, and where appropriate, you refer.

Adverse event escalation

If a patient has a serious adverse event after a procedure at our clinic — a vascular occlusion, an allergic reaction, an infection, a significant emotional dysregulation following treatment — Dr. Fudge is the medical director of record and the clinical escalation contact. Our clinical protocols are designed to his standard.

Mental wellness as an adjacency, not a marketing line

The intersection of mental wellness and aesthetic medicine is now broadly acknowledged across major beauty media. What is less acknowledged is that most medical spas do not have anyone on staff qualified to engage with it clinically. We do. That informs everything from how we counsel patients about realistic expectations, to how we discuss weight loss medication adjuncts, to how we screen for treatment-resistant body image distress that warrants referral.

What this is not

Dr. Fudge is not a dermatologist or a plastic surgeon. We do not claim dermatology training or board certification in dermatology, plastic surgery, or cosmetic medicine, and any media or marketing claim suggesting otherwise would be false. His role is medical direction and clinical governance — not the performance of aesthetic procedures.

Bar Beauty Medical’s injectable, laser, and device treatments are administered by our licensed registered nurse injectors and aesthetic physicians, who carry their own clinical training, certifications, and CPSO/CNO registrations.

For media, researchers, and other clinicians

If you are working on a story, a peer-reviewed paper, or a clinical guideline that touches BDD in cosmetic patient populations, the psychology of repeat-injectable patients, regulatory gaps in Canadian medical aesthetics, or the broader intersection of psychiatry and aesthetic medicine, Bar Beauty Medical is available for expert commentary, founder interviews, and on-the-record clinic visits.

Press contact: basilrusso@hotmail.com · 416-923-1200.